PLOD1 and polycystic ovary syndrome: Concurrently, in vivo studies using an obese PCOS mouse model further validated that butyrate supplementation improves ovarian morphology, suppresses ovarian inflammation, and regulates sex hormone levels, such as follicle-stimulating hormone (FSH), LH, and T.